Search research articles
Contact Us
Filters
Showing results (11-20 of 42) with videos related to
Page
of 5
Sort By:
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica
|
October 22, 2003
[Pharmacological and clinical trial data on a novel phosphate-binding polymer (sevelamer hydrochloride), a medicine for hyperphosphatemia in hemodialysis patients]
Nobuo Nagano, Naoshi Fukushima
Clinical Calcium
|
May 28, 2016
[Pharmacological characteristics of drugs targeted on calcium-sensing receptor.-properties of cinacalcet hydrochloride as allosteric modulator]
Nobuo Nagano, Takaaki Tsutsui
Journal of Pharmacological Sciences
|
March 23, 2005
Functional proteins involved in regulation of intracellular Ca(2+) for drug development: the extracellular calcium receptor and an innovative medical approach to control secondary hyperparathyroidism by calcimimetics
Nobuo Nagano, Edward F Nemeth
Nephron. Clinical Practice
|
November 18, 2014
Fibroblast growth factor 23/klotho axis in chronic kidney disease
Kosaku Nitta, Nobuo Nagano, Ken Tsuchiya
American Journal of Physiology. Endocrinology and Metabolism
|
June 5, 2012
Pathogenesis of secondary hyperparathyroidism and fibroblast growth factor 23: a pharmacological validation of the "trade-off hypothesis"
Nobuo Nagano, Tetsuo Ando, Yohnosuke Shimomura
Contributions to Nephrology
|
May 30, 2015
Klotho/FGF23 Axis in CKD
Ken Tsuchiya, Nobuo Nagano, Kosaku Nitta
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica
|
November 15, 2008
[Pharmacological and clinical profiles of calcimimetics for secondary hyperparathyroidism in chronic kidney disease patients on dialysis (cinacalcet hydrochloride, REGPARA)]
Nobuo Nagano, Takehisa Kawata, Michihito Wada
Clinical Calcium
|
October 2, 2012
[Cinacalcet hydrochloride and phosphate metabolism]
Nobuo Nagano, Tetsuo Ando, Kyoko Ito, et al.
Clinical and Experimental Nephrology
|
October 31, 2025
Association between serum hepcidin-25 levels and hyporesponsiveness to erythropoiesis-stimulating agents in Japanese patients receiving hemodialysis: a cross-sectional study
Ryo Fujikawa, Nobuo Nagano, Yuko Mitobe, et al.
NDT Plus
|
June 29, 2017
The administration of cinacalcet hydrochloride just before a haemodialysis session suppresses the transient rise in intact parathyroid hormone induced by a low-calcium dialysate: when should cinacalcet hydrochloride be administered?
Toshiyuki Date, Yoshiteru Kawashita, Mika Matsuzaki, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 42) with videos related to
Sort By:
Page
of 5
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica
|
October 22, 2003
[Pharmacological and clinical trial data on a novel phosphate-binding polymer (sevelamer hydrochloride), a medicine for hyperphosphatemia in hemodialysis patients]
Nobuo Nagano, Naoshi Fukushima
Clinical Calcium
|
May 28, 2016
[Pharmacological characteristics of drugs targeted on calcium-sensing receptor.-properties of cinacalcet hydrochloride as allosteric modulator]
Nobuo Nagano, Takaaki Tsutsui
Journal of Pharmacological Sciences
|
March 23, 2005
Functional proteins involved in regulation of intracellular Ca(2+) for drug development: the extracellular calcium receptor and an innovative medical approach to control secondary hyperparathyroidism by calcimimetics
Nobuo Nagano, Edward F Nemeth
Nephron. Clinical Practice
|
November 18, 2014
Fibroblast growth factor 23/klotho axis in chronic kidney disease
Kosaku Nitta, Nobuo Nagano, Ken Tsuchiya
American Journal of Physiology. Endocrinology and Metabolism
|
June 5, 2012
Pathogenesis of secondary hyperparathyroidism and fibroblast growth factor 23: a pharmacological validation of the "trade-off hypothesis"
Nobuo Nagano, Tetsuo Ando, Yohnosuke Shimomura
Contributions to Nephrology
|
May 30, 2015
Klotho/FGF23 Axis in CKD
Ken Tsuchiya, Nobuo Nagano, Kosaku Nitta
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica
|
November 15, 2008
[Pharmacological and clinical profiles of calcimimetics for secondary hyperparathyroidism in chronic kidney disease patients on dialysis (cinacalcet hydrochloride, REGPARA)]
Nobuo Nagano, Takehisa Kawata, Michihito Wada
Clinical Calcium
|
October 2, 2012
[Cinacalcet hydrochloride and phosphate metabolism]
Nobuo Nagano, Tetsuo Ando, Kyoko Ito, et al.
Clinical and Experimental Nephrology
|
October 31, 2025
Association between serum hepcidin-25 levels and hyporesponsiveness to erythropoiesis-stimulating agents in Japanese patients receiving hemodialysis: a cross-sectional study
Ryo Fujikawa, Nobuo Nagano, Yuko Mitobe, et al.
NDT Plus
|
June 29, 2017
The administration of cinacalcet hydrochloride just before a haemodialysis session suppresses the transient rise in intact parathyroid hormone induced by a low-calcium dialysate: when should cinacalcet hydrochloride be administered?
Toshiyuki Date, Yoshiteru Kawashita, Mika Matsuzaki, et al.
Page
of 5